The Industrial Research Institute reports that R&D spending by one thousand leading US R&D firms rose 9.9% last year to $216,951.8 million, down from 12.1% growth in 2006. Sales for the firms rose 7.4% last year to $4,999,500.5 million, resulting in R&D totaling 4.3% of sales. R&D as a percentage of profit was 37.9%, as […]
Although electronic lab notebooks (ELNs) have been steadily replacing paper lab notebooks for almost a decade, their acceptance in chemistry-based disciplines has far outweighed their use in biological research. A basic ELN is a device or software that is able to store various laboratory data types, from calculations to notes prepared by researchers. The data […]
On his last day as director of the National Institutes of Health (NIH), Elias Zerhouni formalized the NIH’s policy of setting quotas for the number of grants awarded to new investigators. First instituted in 2007, the quotas are designed to address the decline in the average age of researchers receiving grants. Currently, the average age […]
Carlsbad, CA 11/4/08; Carlsbad, CA and Norwalk, CT 11/11/08—Invitrogen and Applied Biosystems’ merger has received clearance from the European Commission (see IBO 6/15/08). As a result, the companies are expected to complete the transaction on November 21. Invitrogen has also announced that the company will be renamed Life Technologies. Instruments and systems will continue to […]
Market analysis firm New Energy Finance estimates that new investments in clean energy will decline 4% in 2008 to $142 billion. Including existing investments such as acquisitions and buy-outs, deal value is expected to fall 6% to $192 billion. One reason for the decline is public markets. Investment in clean energy via stock markets is […]
Research published in the Journal of the American Medical Association (JAMA) this month indicates that regulatory actions related to safety concerns have been issued for 23.6% of the biological medicinal products approved for sale in the US and EU between January 1995 and June 2008. Of the 174 biologicals approved for sale in the regions […]
Capital spending by the semiconductor industry will not recover until 2010, according to the latest forecast from Gartner. This year, capital expenditures are expected to decline 25.7% to $47.1 billion, the biggest drop since 2002. Gartner attributes the decline to economic conditions and overcapacity in the memory business. The capital intensity of the semiconductor industry […]
IMS forecasts worldwide pharmaceutical sales to increase 4.5%–5.5%, in 2009, the same as 2008’s growth, to more than $820 billion. Oncology products will drive growth, with sales expected to increase 15%–16%. Also driving sales growth will be HIV therapies, which are forecasted to grow 13%–14%, and biologics, which are expected to grow 11%–12%. Sales of […]
Electrofusion, also known as cell-cell electrofusion or electrically mediated cell-cell fusion, is the fusion of two cells, mediated by electrical stimulation. Dr. Mitsugi Senda first reported this technique in 1979 when he fused two plant protoplasts by using capillary microelectrodes and applying electric current. In 1981, Dr. Ulrich Zimmerman built upon Dr. Senda’s study and […]
Donations to charities and other nonprofit institutions that fund medical research could be at risk due to the economic crisis. According to the Center on Philanthropy at the University of Indiana, the level of donations made to charities correlates with the fortunes of the stock markets, but any effects from the current crisis would not […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
